Close on 09 Oct 2026
All US Equities (S&P 500 / NASDAQ-100)

Gilead Sciences

GILDUS Listed
Exchange: NASDAQ · Market: US Equities · Currency: USD

Gilead Sciences (GILD) is a leading publicly traded corporation listed in the United States, constituent of the S&P 500 and NASDAQ-100 index.

Sector: Health Care·Indices: S&P 500, NASDAQ-100·Market Cap: $186.53B
Close on 16 Oct 2026
$156.19
-1.18 (-0.75%)
Last updated: 16 Oct 2026 (US Market EOD settlement)

Stock Snapshot & Key Numbers — Gilead Sciences

Verified Daily Close

Official closing price, 1-year price range, valuation multiples, and market value from exchange records.

Last Session Move
Down -0.75% on 16 Oct 2026
Position vs 1-Year High
0.7% below 52W High
P/E Valuation Multiple
Not Reported / Loss
Annual Cash Dividend
2.17% Dividend Yield
Close on 16 Oct 2026
$156.19
-1.18 (-0.75%)vs prev close
1-Year Low to High Range97% of range
Low: $118High: $157
Valuation (P/E, P/B & Dividend)
P/E Ratio (Price / Profit):N/A
P/B Ratio (Price / Book):15.8x
Dividend Yield:2.17%
Total Company Value (Market Cap)
$186.53B
Sector: Health Care
Latest Official Announcement:Gilead Sciences shares decline 1.36% ahead of first quarter earnings - Livemint
5mo ago
Plain-English Company Summary

Gilead Sciences (GILD) is a US equity security listed on the NASDAQ. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at $156.19, recording a -1.18 (-0.75%) decline from its previous close of $157.37. Over the trailing 52-week trading cycle, GILD has traded between a 52-week low of $117.85 and a 52-week high of $157.37, establishing its annual trading channel. In historical performance, Gilead Sciences has gained 32.53% over the past 1 year. Period returns across standard measurement intervals include: 1-week: +3.32%, 1-month: +5.76%, 6-month: +12.73%, 1-year: +32.53%, 3-year: +97.21%, 5-year: +137.01%. Daily reported trading volume reached 7,770,900 equity shares. On key valuation multiples as of Oct 13, 2026, the company trades at a trailing price-to-earnings (P/E) multiple of not meaningful (negative earnings) and a price-to-book (P/B) ratio of 15.8x, with a trailing dividend yield of 2.17%. Its market capitalization stands at $186.53B. The company is categorized under the Health Care sector and S&P 500 & NASDAQ-100 industry within the US equities universe.

Price Chart

1Y: +32.53% (₹38.34)
₹157₹144₹131₹118Thu, 16 Oct, 2025Fri, 16 Oct, 2026

Trading Multiples & Ranges

Price boundaries and liquidity distribution.

52-Week Range$117.85 – $157.37
Low: $117.85High: $157.37
$117.85$157.37
Trailing P/E Ratio—
Price to Book (P/B)15.78x
Dividend Yield2.17%
Day High / Low$155.62 – $157.58
Daily Volume7.77M

Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)

How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).

1 Month Holding Period (21 trading days)
1,234 past 21-day periods analyzed
Fell 15.2%
Within ±5% (57.7%)
Rose 27.1%
Fell > 5%
15.2%
188 windows
Within ±5%
57.7%
712 windows
Rose > 5%
27.1%
334 windows
In 80% of past 1 month windows the move was within ±7.8%.
Historical outcomes of this stock's own price. Not a forecast. (1255 trading days of history).
How to read historical odds

At-a-Glance Health & Momentum Check

Market Mood: Consolidation / Rangebound
News Activity
ACCELERATING
Recent announcement pace
Profit & Margin Trend
EXPANDING
Earnings & margin direction
Economy Sensitivity
MODERATE
Impact of rates, oil & FX
Broad Market Mood
Consolidation / Rangebound
Current market trend
News Tone
NEGATIVE SCRUTINY
Recent filing tone
What This Means(based on reported financials)

Recent exchange filings and reported financial statements show healthy alignment between revenue growth, operating cash flow, and improving profit margins.

Active Risk Flags & Monitoring Constraints
Elevated regulatory and disclosure event clustering in observation window

How Outside Factors Affect This Stock (Market, Crude Oil & Currency)

How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.

Swing Rank: 50th percentile
Typical 1-Year Price Swing (Volatility): 26.8% annualized
Price Swing Level vs Market: Moderate Swings
Factor / Benchmark1Y Beta (Sensitivity)1Y Correlation (-1 to +1)What This Means
S&P 500+0.35+0.17Trailing 1Y historical sensitivity: a 1% move in S&P 500 coincided with a +0.35% co-movement (correlation: 0.17). Descriptive historical relationship, not predictive.
US 10Y Treasury Yield-0.44-0.24Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a -0.44% co-movement (correlation: -0.24). Descriptive historical relationship, not predictive.
Brent Crude Oil-0.07-0.14Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.07% co-movement (correlation: -0.14). Descriptive historical relationship, not predictive.
USD / INR+0.02+0.01Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a +0.02% co-movement (correlation: 0.01). Descriptive historical relationship, not predictive.
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾

Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.

Trailing Returns Breakdown

Calendar-aligned historical percentage performance across standard market windows.

PeriodStart PriceCurrent PriceReturn (%)
1 Week₹151.17₹156.19+3.32%
15 Days₹147.50₹156.19+5.89%
1 Month₹147.68₹156.19+5.76%
3 Months₹136.30₹156.19+14.59%
6 Months₹138.55₹156.19+12.73%
1 Year₹117.85₹156.19+32.53%
3 Years₹79.20₹156.19+97.21%
5 Years₹65.90₹156.19+137.01%

Price Swings & Biggest Historical Drops

How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.

1Y Yearly Swing
26.8%
Annualized volatility
1Y Beta vs Index
0.35
vs benchmark index
Biggest 1Y Drop
-22.0%
1Y peak-to-low drop
Biggest 5Y Drop
-29.4%
5Y peak-to-low drop
vs 52W High
-0.8%
Distance from 1Y high
vs 52W Low
+32.5%
Gain above 1Y low

Calendar-Year Historical Performance

Annual performance breakdown comparing first and last closing sessions of each calendar year.

Calendar YearStart CloseEnd CloseAnnual ReturnTrajectory Bar
CY 2026₹121.60₹156.19+28.4%
CY 2025₹91.88₹122.74+33.6%
CY 2024₹83.24₹92.37+11.0%
CY 2023₹85.39₹81.01-5.1%
CY 2022₹72.58₹85.85+18.3%
CY 2021₹65.90₹72.61+10.2%

Corporate Actions History

No dividend or stock split distributions recorded in historical feeds for GILD.

Historical Investment Simulator

Factual simulation of past returns in Gilead Sciences (GILD) using real recorded closing prices.

₹1,00,000.00
5 Years
Principal Invested
₹1,00,000.00
₹1,00,000.00 starting capital
Portfolio Value Today
₹2,37,010.60
Based on latest close
Absolute Return
+137.0%
+₹1,37,010.60
Annualized (CAGR)
+18.9%
Compound annual growth
Entry Price: ₹65.90 · Exit Price: ₹156.19
Simulated 5Y period (INR)

Recent News & Official Exchange Announcements

Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.

Showing 5 of 8 Updates
#1 EARNINGSLODR Materiality: 99/100Business HeadwindBackground ContextDirect Mention
5mo ago

Gilead Sciences shares decline 1.36% ahead of first quarter earnings - Livemint

Gilead Sciences shares decline 1.36% ahead of first quarter earnings Livemint

Valuation Impact:-2.5% to -6.0% (EBITDA Margin Compression Risk)
Inspecting in Causal Panel
Source: Livemint·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped
#2 EARNINGSLODR Materiality: 86/100Neutral / RoutineRecent EventDirect Mention
1d ago

Gilead Sciences Q3FY26 Results: Earnings release set for October 29, 2026 - scanx.trade

Gilead Sciences Q3FY26 Results: Earnings release set for October 29, 2026 scanx.trade

Valuation Impact:±1.0% (In-line Quarterly Disclosure)
Click to analyze
Source: scanx.trade·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped
#3 GENERALLODR Materiality: 68/100Neutral / RoutineRecent EventDirect Mention
1d ago

Gilead Sciences to present at three major healthcare conferences in September - scanx.trade

Gilead Sciences to present at three major healthcare conferences in September scanx.trade

Valuation Impact:±0.5% (Neutral Fundamental Range)
Click to analyze
Source: scanx.trade·Horizon: SHORT_TERM
SEBI LODR Reg 30 Mapped
#4 GENERALLODR Materiality: 68/100Neutral / RoutineOngoing ImpactDirect Mention
1mo ago

Gilead Sciences delivers 15.54% annualized return over five years - scanx.trade

Gilead Sciences delivers 15.54% annualized return over five years scanx.trade

Valuation Impact:±0.5% (Neutral Fundamental Range)
Click to analyze
Source: scanx.trade·Horizon: SHORT_TERM
SEBI LODR Reg 30 Mapped
#5 EARNINGSLODR Materiality: 78/100Neutral / RoutineBackground Context
3mo ago

Dr Reddy stock reports lower Q1 earnings - ad-hoc-news.de

Dr Reddy stock reports lower Q1 earnings ad-hoc-news.de

Valuation Impact:±1.0% (In-line Quarterly Disclosure)
Click to analyze
Source: ad-hoc-news.de·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped

Why This Matters for the Business

Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.

Event 1 of 5
Causal Attribution in Focus
EARNINGS·5mo ago
Verified Exchange / Wire Disclosure:
Gilead Sciences shares decline 1.36% ahead of first quarter earnings - Livemint
Source: Livemint·LODR Materiality: 99/100Headwind
3-Stage Transmission Mechanism:
1. Disclosure Trigger
Quarterly Financial Milestone & Operating Margins
2. Sector Transmission
Sector-wide volume demand absorption & operating leverage
3. GILD Accretion
-2.5% to -6.0% (EBITDA Margin Compression Risk)
Causal Attribution Analysis:Direct Named Awardee

Operating performance or EBITDA margins lagged market expectations, triggering multiples compression.

Extracted Factual Evidence:
  • •Direct quantitative change registered at 1.36%
  • •Top-line revenue or operating profitability registered contraction vs previous comparative period
P&L Operating Leverage

Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across health care units.

Order Book & Revenue Visibility

Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.

Affected Financial Metrics:
Operating EBITDA MarginRevenue VisibilityNet Income (PAT)
Cross-asset macro betas (Brent Crude, USD/INR, NIFTY) are mapped in the dedicated dependency engine.
View Graph
Evidence Integrity: Hypotheses and attribution models are anchored strictly in verified regulatory disclosures, public tenders, and audited financial statements across a trailing 6-month capital cycle.

Common Questions About Gilead Sciences (GILD)

Key facts on GILD share price, historical returns, valuation ratios, and past SIP performance.

What is the current share price and 52-week range of Gilead Sciences (GILD)?

As of 16 Oct 2026, the official closing share price of Gilead Sciences (GILD) on NASDAQ is $156.19 (-0.75% vs the previous close). Over the past 52 weeks, GILD has traded between a low of $117.85 and a high of $157.37, with a reported market capitalization of $186.53B.

What are the historical returns of Gilead Sciences (GILD)?

Based on split-adjusted closing prices through 16 Oct 2026, Gilead Sciences (GILD) recorded the following trailing price returns: 1 Week: +3.32% (from $151.17 to $156.19); 15 Days: +5.89% (from $147.50 to $156.19); 1 Month: +5.76% (from $147.68 to $156.19); 3 Months: +14.59% (from $136.30 to $156.19); 6 Months: +12.73% (from $138.55 to $156.19); 1 Year: +32.53% (from $117.85 to $156.19); 3 Years: +97.21% (from $79.20 to $156.19); 5 Years: +137.01% (from $65.90 to $156.19). Past performance reflects historical exchange records and does not predict future returns.

What is the P/E ratio, P/B ratio, and dividend yield of Gilead Sciences (GILD)?

Gilead Sciences (GILD) currently trades at a trailing Price-to-Earnings (P/E) ratio of not applicable (or negative trailing earnings), a Price-to-Book (P/B) ratio of 15.8x, and a trailing 12-month dividend yield of 2.17%. It operates in the Health Care sector (S&P 500 & NASDAQ-100).

How much would a past lump-sum or monthly SIP investment in GILD have grown?

Based on historical closing prices for Gilead Sciences (GILD): A one-time lump-sum investment of $10000.00 held for 5 years would be worth $23701.06 (+137.0% total return, 18.9% CAGR), while a monthly SIP of $500.00 over 5 years (total invested: $30500.00) would be worth $56120.00 (+84.0% absolute return). You can test custom amounts and holding periods in the interactive calculator above.